Concurrently with the genetic inactivation of the Rbp1 gene, pharmacological modulation of RBP1 activity with abnormal cannabidiol (abn-CBD) and other nonretinoid inhibitors provided substantial protection against retinal degeneration in Abca4−/−/Rdh8−/− mice. The gene discussed is RBP1; the disease is retinal degeneration.